In human melanomas, over-expression of MAGE-A, a cancer-germline antigen, is associated with CTLA-4 blockade resistance and can downregulate autophagy, suggesting autophagy induction as a potential therapeutic approach to improve CTLA-4 inhibitors efficacy (203). Here, CTLA4 is linked to melanoma.